Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-Dioxygenase

Journal of Experimental Medicine - Tập 196 Số 4 - Trang 459-468 - 2002
Guido Frumento1, Rita Rotondo1, Michela Tonetti2, Gianluca Damonte2, Umberto Benatti2, Giovanni Battista Ferrara1,3
11Immunogenetics Laboratory, National Cancer Research Institute
22Biochemistry Section, Experimental Medicine Department
33Oncology, Biology and Genetics Department, University of Genoa, and Advanced Biotechnology Center, 16132 Genoa, Italy

Tóm tắt

Macrophages exposed to macrophage colony-stimulating factor acquire the capacity to suppress T cell proliferation; this effect is associated with de novo expression of the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO). We have purified IDO and tested its activity in in vitro models of T cell activation. IDO was able to inhibit proliferation of CD4+ T lymphocytes, CD8+ T lymphocytes, and natural killer (NK) cells; proliferation of B lymphocytes was not affected. The inhibitory role of tryptophan and of its catabolites was then tested. In the presence of tryptophan, only l-kynurenine and picolinic acid inhibit cell proliferation. In a tryptophan-free medium cell proliferation was not affected. In the absence of tryptophan inhibition induced by l-kynurenine and picolinic acid was observed at concentrations below the lowest concentration that was effective in the presence of tryptophan, and quinolinic acid acquired some inhibitory capacity. Inhibition of cell proliferation induced by the tryptophan catabolites resulting from IDO activity was selective, applying only to cells undergoing activation. Resting cells were not affected and could subsequently activate normally. We suggest that IDO exerts its effect on cell proliferation by (i) starting the cascade of biochemical reactions that produce the three catabolites and by (ii) enhancing their inhibitory potential by depriving the extracellular microenvironment of tryptophan.

Từ khóa


Tài liệu tham khảo

1991, FASEB J., 5, 2516, 10.1096/fasebj.5.11.1907934

2000, Immunol. Today., 21, 250

1999, Immunol. Today., 20, 469, 10.1016/S0167-5699(99)01520-0

1998, Science., 281, 1191, 10.1126/science.281.5380.1191

2001, Nat. Immunol., 2, 64, 10.1038/83183

1999, J. Exp. Med., 189, 1363, 10.1084/jem.189.9.1363

1978, J. Biol. Chem., 253, 4700, 10.1016/S0021-9258(17)30447-7

1976, Anal. Biochem., 72, 248, 10.1016/0003-2697(76)90527-3

1988, J. Biol. Chem., 263, 2041, 10.1016/S0021-9258(19)77982-4

1996, J. Immunol, 156, 523, 10.4049/jimmunol.156.2.523

1991, J. Immunol. Methods, 139, 271, 10.1016/0022-1759(91)90198-O

1990, Biochem. Biophys. Res. Commun., 166, 1398, 10.1016/0006-291X(90)91022-K

1975, J. Biol. Chem., 250, 5960, 10.1016/S0021-9258(19)41144-7

1991, Arch. Biochem. Biophys., 291, 326, 10.1016/0003-9861(91)90142-6

1989, Immunol. Today., 10, 92, 10.1016/0167-5699(89)90234-X

1967, J. Biol. Chem., 242, 5260, 10.1016/S0021-9258(18)99420-2

2000, J. Immunol., 164, 3596, 10.4049/jimmunol.164.7.3596

Thông tin
Thông tin xuất bản

Journal of Experimental Medicine

Tập 196 Số 4

459-468

Thông tin tác giả